This section of the website contains information that should be considered accurate as of the date presented. You acknowledge that this information may change over time and you should not assume that the information is accurate at a later date. Quest Diagnostics is not obligated to update the information contained in this section of the website.
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, and Lee Health, Southwest Florida's primary community-owned health system, are teaming up to enhance...
Quest Diagnostics Incorporated (NYSE: DGX), the world's leading provider of diagnostic information services, announced that it is scheduled to speak at the Morgan Stanley 20th Annual Global...
First lab-developed test specifically designed to detect Monkeypox virus DNA to receive emergency use authorization during the monkeypox public health emergency SECAUCUS, N.J., Sept. 7, 2022...
New test panel follows a Quest Diagnostics Health Trends® study with the CDC that revealed less than half of pregnant people are screened for hepatitis C as recommended under guidelines SECAUCUS,...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced that its Board of Directors declared a quarterly cash dividend of $0.66 per share,...
DALLAS, August 5, 2022 — The American Heart Association, the world’s leading nonprofit organization focused on longer, healthier lives for all, is committed to addressing the lack of diversity...
Better healthcare among America's large and growing Hispanic community is receiving an important, new level of support from Quest Diagnostics, the world's leading provider of diagnostic...
SECAUCUS, N.J., (August 3, 2022) - Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been recognized by Forbes as one of America’s...
Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, announced it has been named to the 2022 Disability Equality Index® (DEI) Best Places to Work for...
Analysis of nearly 23 million lab tests finds only 1 in 3 patients with latent tuberculosis were also tested for chronic hepatitis B, despite similar risk factors in patients Findings heighten...